Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-arm double-blind randomized trial of L-PRP vs botulinum toxin A vs glucocorticoid injection for lateral epicondylalgia
2014-001300-22Phase 3Terminated
- Sponsor
- CHU Nîmes
- Start
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A, cortivazol and Leukocyte-Rich Platelet-Rich Plasma in Lateral Epicondylitis (LET) (3 arms), sponsored by CHU Nîmes. Primary endpoints: Mean pain over the last 24 hours, Maximum pain and 1 more. Started Jun 2015; status: terminated.
02
Drugs
botulinum toxin type AcortivazolLeukocyte-Rich Platelet-Rich Plasma
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on 2014-001300-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001300-22.